AbbVie Inc (ABBV)

pos +0.00
Today's Range: 59.61 - 60.45 | ABBV Avg Daily Volume: 10,751,500
Last Update: 11/27/15 - 1:01 PM EST
Volume: 0
YTD Performance: -8.31%
Open: $0.00
Previous Close: $60.29
52 Week Range: $45.45 - $71.60
Oustanding Shares: 1,634,746,917
Market Cap: 98,558,891,626
6-Month Chart
TheStreet Ratings Grade for ABBV
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 10 10 9 10
Moderate Buy 1 0 0 0
Hold 1 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.21 1.33 1.36 1.33
Latest Dividend: 0.57
Latest Dividend Yield: 3.78%
Dividend Ex-Date: 01/13/16
Price Earnings Ratio: 32.95
Price Earnings Comparisons:
ABBV Sector Avg. S&P 500
32.95 35.20 32.68
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-6.99% -12.66% 0.00%
Revenue 6.20 0.14 0.05
Net Income -57.00 -0.48 -0.20
EPS -57.20 0.00 0.00
Earnings for ABBV:
Revenue 19.96B
Average Earnings Estimates
Qtr (12/15) Qtr (03/16) FY (12/15) FY (12/16)
Average Estimate $1.14 $1.13 $4.29 $5.00
Number of Analysts 7 2 8 8
High Estimate $1.20 $1.16 $4.30 $5.05
Low Estimate $1.10 $1.10 $4.27 $4.94
Prior Year $0.89 $0.94 $3.32 $4.29
Growth Rate (Year over Year) 27.93% 20.21% 29.07% 16.74%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
The sector saw solid performance this week as the biotech juggernaut mounted a long-overdue rally.

Gilead Leads a Biotech Rally Real Money Pro($)

The sector saw solid performance this week as the biotech juggernaut mounted a long-overdue rally.
These two will continue to churn out earnings growth.
The market has strengthened some since my last update.
AbbVie, Teva and Zimmer Biomet posted solid quarters and are upbeat about the road ahead.
Nov 02, 2015 | 7:09 AM EST
ABBV was upgraded from Equal-weight to Overweight, Morgan Stanley said. $73 price target. Estimates also boosted, given the company's n...
Markets are now up slightly in what is one of most listless trading sessions to end a month that I recall lately. Not much moving. 

3 Stocks to Watch Today Real Money Pro($)

Futures are up as we get less than an hour from the opening bell for October's last trading day.
The Apple breakout over $117 now measures to $127.
ABBV gets FDA warning on Viekira Pak drug, GILD reaps the reward.

Columnist Conversations

Market flat in shortened trading day despite China's markets having biggest plunge of month as authorities cra...
Disney options among the most active as shares slip nearly 3% following poor ESPN numbers. Nearly 30K contract...
Top selling Black Friday items:


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.